UNSPSC 51102825: Benzalkonium/oxyquinoline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102825 Benzalkonium/oxyquinoline is a Commodity code that does not align with recent state and local procurement activity posted under it. The two most recent opportunities tagged to this code involve antibiotic pharmaceuticals (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and harm-reduction products (Naloxone and drug deactivation systems), neither of which matches the benzalkonium/oxyquinoline classification. The code shows little relevant recent activity that tracks to its nominal scope.

State and local procurement offices appear to be using this code inconsistently or as a catch-all for pharmaceutical purchases that fall outside more precise classifications. The Illinois Department of Public Health awarded a completed piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over three years for antibiotic supply, while Seminole County, Florida posted an IFB on June 30, 2026, for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries. Neither solicitation represents a benzalkonium/oxyquinoline product line. Business development professionals should verify the actual commodity codes under which relevant pharmaceutical or health-product procurements are tagged before committing resources to this code.